Could CMS Changes To Bundled Pay Models Stifle Medtechs' Value-Based Pay Plans?

The US Center for Medicare and Medicaid Services proposed downsizing its CJR joint replacement value-based payment model and outright canceling its cardiac procedure bundled payment model. Will the move discourage companies like Zimmer Biomet, Johnson & Johnson, and Medtronic, which have already invested in programs based on the value-based models?

While newly-proposed changes to bundled payment programs linked to orthopedic and cardiovascular procedures from the US Centers for Medicare and Medicaid Services (CMS) may signal a step away from mandatory value-based payment models, medtech companies say such models will continue to improve efficiencies in costs and patient care.

CMS on Aug. 15 proposed rules to reduce the number of geographic areas participating in its "Comprehensive Care for Joint Replacement" (CJR) payment program, and would...

More from Policy & Regulation

More from Medtech Insight